Key Earning Takeways For Monster Beverage Corporation (NASDAQ:MNST), Valeant Pharmaceuticals (NYSE:VRX), Dean Foods Co (NYSE:DF)

Keeping an eye on the Q2 earnings of the different stocks can help you make some good investment strategies. Let us see what they are.

Among other companies, Monster Beverage Corporation (NASDAQ:MNST) seems to beat the expectations. The company beat their sales expectation and even the second quarter earnings, but their shares fell by nearly 6% on late Tuesday. The company spoke about their production shortages issues. Monster Beverage Corporation (NASDAQ:MNST) recorded a total income of $222.6 million as compared to $184.2 million last year. The sales figure seems to have increased by 10%. Unfavourable currency exchange rates and production shortages were main bottlenecks.

Monster Beverage Corporation
Monster Beverage Corporation

Further, stocks for Valeant Pharmaceuticals Intl Inc (NYSE:VRX) seem to have shot high by 7.9% on the premarket trade on Tuesday. The company though reported a second quarter loss and they have also announced a cut in their 2017 revenue guidance as well. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) ended up with a loss of $38 million, but this is quite a major improvement compared to the loss figures last year for the same quarter which was $302 million.

Valeant Pharmaceuticals
Valeant Pharmaceuticals

The shares for Dean Foods Co (NYSE:DF) have seen a fall of 13% as their earning turned out to be way less than the expectations. The company reported a net income of $91.37 million. The last year earning during the same quarter was $91.68 million. Dean Foods Co (NYSE:DF) revenue has improved considerably since last year and was recorded at $1.93 billion but it was still less than the FactSet’s consensus. The chief executive of the company blamed the volume pressure from a macro level and even high competitive streak for their sloppy performance.

Share this post

Leave a Reply